Nordicus Partners Corp (NORD)

Nordicus Partners Corp. is a publicly traded common stock listing on OTC Markets under the symbol NORD. The company describes itself as a business accelerator and holding company focused on Nordic life sciences companies in the United States. Its activities include supporting medicine development with an emphasis on oral health, along with corporate finance-related services such as business and market development, growth planning, talent acquisition, partnership formation, capital raising, and assistance with company acquisitions and sales. Founded in 1993 and based in Beverly Hills, California, the company was previously known as EKIMAS Corporation before adopting its current name in May 2023.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-NORD
$3.59
6.2% Upside
Fair
Not available
Not available
Fair
0.0%
November 13, 2026
0.8x
65.72 M
50.827 M
0.1%
44.8%
-27.3
108.5%
Valuation • Fair Value

Nordicus Partners Corp (OTC-NORD) Fair Value by Valuation Model

Review the available estimates for Nordicus Partners Corp (OTC-NORD), including Comps Fair Value.

Primary Valuation Read

Fair Value

$3.59

Estimated upside of 6.2% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Comps Fair Value

$3.59

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 3 available valuation references for Nordicus Partners Corp (OTC-NORD) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Nordicus Partners Corp (OTC-NORD)

Review the profitability and growth indicators currently supported by the latest data.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Nordicus Partners Corp (OTC-NORD) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Nordicus Partners Corp (OTC-NORD)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

1

Weak quality score that deserves closer review.

Altman Z-Score

-27.3

Lower score that deserves closer risk review.

FCF / Net Income

108.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Nordicus Partners Corp (OTC-NORD). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Nordicus Partners Corp (OTC-NORD)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 13, 2026

Days to Earnings

52

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Nordicus Partners Corp (OTC-NORD), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Nordicus Partners Corp (OTC-NORD) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Nordicus Partners Corp (OTC-NORD) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Nordicus Partners Corp (OTC-NORD) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Nordicus Partners Corp (OTC-NORD) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Nordicus Partners Corp (OTC-NORD) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Nordicus Partners Corp (OTC-NORD) Stock FAQ

Data-supported answers about Nordicus Partners Corp (OTC-NORD), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$3.59
Estimated upside 6.2%
Valuation Rating
Undervalued
Estimated upside of 6.2%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Nordicus Partners Corp (OTC-NORD) is $3.59. This implies an estimated upside of 6.2% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 6.2% versus the current market price.

The current financial health read for Nordicus Partners Corp (OTC-NORD) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Nordicus Partners Corp (OTC-NORD) is November 13, 2026.

The latest available data indicates no current dividend yield for Nordicus Partners Corp (OTC-NORD).

The current market capitalization listed for Nordicus Partners Corp is 65.72 M.

The current enterprise value listed for Nordicus Partners Corp is 50.827 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Nordicus Partners Corp is OTC-NORD, and the stock is listed on OTC Markets.

Nordicus Partners Corp (OTC-NORD) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Nordicus Partners Corp is 0.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Nordicus Partners Corp is 44.8%. Free float helps investors understand how much of the share base is available for public trading.